academic article

• The Circadian Hormone Melatonin Inhibits Morphine-Induced Tolerance and Inflammation via the Activation of Antioxidative Enzymes..  Antioxidants (Basel, Switzerland).  9:-. 2020
• Shea Nut Oil Extracts Enhance the Intra-Articular Sodium Hyaluronate Effectiveness on Surgically Induced OA Progression in Rats..  Nutrients.  12:-. 2020
• Melatonin and their analogs as a potential use in the management of Neuropathic pain..  Journal of the Formosan Medical Association = Taiwan yi zhi.  118:1177-1186. 2019
• Melatonin regulation of transcription in the reversal of morphine tolerance: Microarray analysis of differential gene expression..  International journal of molecular medicine.  43:791-806. 2019
• Oral shea nut oil triterpene concentrate supplement ameliorates pain and histological assessment of articular cartilage deterioration in an ACLT injured rat knee osteoarthritis model..  PloS one.  14:-. 2019
• High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. 2017
• Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults..  Blood.  129:572-581. 2017
• High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL..  Leukemia.  :-. 2017
• Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  129:177-187. 2017
• Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 2016
• Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia..  Nature communications.  7:-. 2016
• Characterization of leukemias with ETV6-ABL1 fusion..  Haematologica.  101:1082-1093. 2016
• Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells..  ACS nano.  :-. 2016
• MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study..  Leukemia.  :-. 2016
• Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia..  Cancer cell.  29:186-200. 2016
• Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia..  Molecular cancer therapeutics.  14:364-374. 2015
• Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia..  Nature communications.  6:-. 2015
• Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
• Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project..  Blood.  121:485-488. 2013
• Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia..  Blood.  120:833-842. 2012
• Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML..  Blood.  120:1473-1484. 2012
• Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:1872-1881. 2012
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia..  Cancer cell.  22:153-166. 2012
• Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:3512-3522. 2012
• Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  120:3510-3518. 2012
• Treatment-influenced associations of PML-RAR? mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia..  Blood.  120:2098-2108. 2012
• GSI-I (Z-LLNle-CHO) inhibits ?-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia..  Leukemia.  25:1135-1146. 2011
• Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group..  Blood.  118:3080-3087. 2011
• Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia..  Blood.  115:1394-1405. 2010
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome..  Blood.  116:4874-4884. 2010
• Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia..  Blood.  115:5312-5321. 2010
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia..  The New England journal of medicine.  360:470-480. 2009
• JAK mutations in high-risk childhood acute lymphoblastic leukemia..  Proceedings of the National Academy of Sciences of the United States of America.  106:9414-9418. 2009
• Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia..  Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K.  21:1341-1344. 2007
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis..  Nature medicine.  12:945-949. 2006
• Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction..  Blood.  108:685-696. 2006
• Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method..  British journal of haematology.  135:358-361. 2006
• Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia..  American journal of clinical pathology.  122:783-793. 2004